Jiva Technologies Reports Significant Year-Over-Year Improvement in Financial Results, Showcasing Stronger Operating Efficiencies and Strategic Growth
Jiva Technologies (OTCQB: PLTXF), a wellness technology company, reported significant financial improvements for fiscal year 2025. The company achieved revenue of $4.6 million and reduced its net loss to $651,981 from $3.3 million in the previous year, with loss per share improving to $(0.45) from $(3.99).
Key operational highlights include an 84% reduction in advertising expenses, improved operating cash flow to $(873,632), and a Q1 2025 gross margin of 64%. The company benefited from a $1.81 million gain from derivative liability changes and $485,705 in other income. Q1 2025 showed an operating income of $170,000 compared to a $278,000 loss in 2024, with a cash balance of $196,000 as of June 30.
Jiva Technologies (OTCQB: PLTXF), azienda nel settore del benessere tecnologico, ha comunicato miglioramenti finanziari significativi per l'esercizio 2025. Ha realizzato ricavi per 4,6 milioni di dollari e ha ridotto la perdita netta a 651.981 dollari rispetto ai 3,3 milioni dell'anno precedente; la perdita per azione è scesa a (0,45$) da (3,99$).
Tra i principali risultati operativi si segnala una riduzione dell'84% delle spese pubblicitarie, un miglioramento del flusso di cassa operativo a (873.632$) e un margine lordo del 64% nel primo trimestre del 2025. La società ha beneficiato di un utile di 1,81 milioni di dollari derivante da variazioni delle passività derivati e di 485.705 dollari di altri proventi. Nel Q1 2025 l'utile operativo è stato di 170.000 dollari rispetto a una perdita di 278.000 nel 2024, con una posizione di cassa pari a 196.000 dollari al 30 giugno.
Jiva Technologies (OTCQB: PLTXF), compañÃa de tecnologÃa para el bienestar, anunció mejoras financieras significativas para el año fiscal 2025. Registró ingresos de 4,6 millones de dólares y redujo su pérdida neta a 651.981 dólares desde 3,3 millones el año anterior; la pérdida por acción mejoró a (0,45$) desde (3,99$).
Entre los puntos operativos destacados figura una reducción del 84% en gastos publicitarios, una mejora del flujo de caja operativo a (873.632$) y un margen bruto del 64% en el primer trimestre de 2025. La compañÃa obtuvo un ganancia de 1,81 millones de dólares por cambios en pasivos derivados y 485.705 dólares en otros ingresos. En el Q1 2025 presentó un resultado operativo de 170.000 dólares frente a una pérdida de 278.000 en 2024, y un saldo de efectivo de 196.000 dólares al 30 de junio.
Jiva Technologies (OTCQB: PLTXF), 웰니ìŠ� ê¸°ìˆ ê¸°ì—…ì€ 2025 회계연ë„ì—� ìœ ì˜ë¯¸í•œ 재무 ê°œì„ ì� ë³´ê³ í–ˆìŠµë‹ˆë‹¤. 매출 460ë§� 달러ë¥� 달성했으ë©� 순ì†ì‹¤ì„ ì „ë…„ 330ë§� 달러ì—서 651,981달러ë¡� 줄였ê³�, 주당 ì†ì‹¤ì€ (0.45달러)ë¡� (3.99달러)ì—서 ê°œì„ ë˜ì—ˆìŠµë‹ˆë‹�.
주요 ìš´ì˜ í•˜ì´ë¼ì´íŠ¸ë¡œëŠ� ê´‘ê³ ë¹� 84% 축소, ì˜ì—…현금í름 ê°œì„ (ì˜ì—…현금í름: (873,632달러)), 2025ë…� 1분기 매출ì´ì´ìµë¥ 64% ë“±ì´ ìžˆìŠµë‹ˆë‹¤. 회사ëŠ� 파ìƒìƒí’ˆ ë¶€ì±� ë³€ë™ìœ¼ë¡� ì¸í•œ 181ë§� 달러ì� ì´ìµê³� 485,705달러ì� 기타 수ìµì� 기ë¡í–ˆìŠµë‹ˆë‹¤. 2025ë…� 1분기 ì˜ì—…ì´ìµì€ 17ë§� 달러ë¡� 2024ë…„ì˜ 27.8ë§� 달러 ì†ì‹¤ì—서 í‘ìžë¡� ì „í™˜í–ˆìœ¼ë©�, 6ì›� 30ì� 기준 현금 ìž”ì•¡ì€ 196,000달러였습니ë‹�.
Jiva Technologies (OTCQB: PLTXF), société de technologies du bien‑être, a annoncé des améliorations financières significatives pour l'exercice 2025. Elle a enregistré un chiffre d'affaires de 4,6 millions de dollars et réduit sa perte nette à 651 981 dollars contre 3,3 millions l'année précédente ; la perte par action est passée à (0,45$) contre (3,99$).
Parmi les principaux faits opérationnels : une réduction de 84% des dépenses publicitaires, une amélioration du flux de trésorerie d'exploitation à (873 632$) et une marge brute de 64% au T1 2025. La société a bénéficié d'un gain de 1,81 million de dollars lié aux variations des passifs dérivés et de 485 705 dollars d'autres produits. Au T1 2025, le résultat d'exploitation s'est établi à 170 000 dollars contre une perte de 278 000 en 2024, et la trésorerie s'élevait à 196 000 dollars au 30 juin.
Jiva Technologies (OTCQB: PLTXF), ein Unternehmen für Wellness-Technologie, meldete für das Geschäftsjahr 2025 deutliche finanzielle Verbesserungen. Das Unternehmen erzielte Umsätze von 4,6 Mio. USD und verringerte den Nettoverslust auf 651.981 USD gegenüber 3,3 Mio. USD im Vorjahr; der Verlust je Aktie verbesserte sich auf (0,45 USD) von (3,99 USD).
Wesentliche operative Highlights sind eine Reduzierung der Werbeausgaben um 84%, eine Verbesserung des operativen Cashflows auf (873.632 USD) sowie eine Bruttomarge von 64% im ersten Quartal 2025. Das Unternehmen profitierte von einem Gewinn von 1,81 Mio. USD durch Veränderungen bei derivativen Verbindlichkeiten und 485.705 USD sonstigen Erträgen. Im Q1 2025 lag das operative Ergebnis bei 170.000 USD gegenüber einem Verlust von 278.000 USD in 2024; die Kassenbestände beliefen sich zum 30. Juni auf 196.000 USD.
- Net loss significantly reduced by 80% to $651,981 from $3.3 million
- Operating income improved to $170,000 in Q1 2025 from -$278,000 loss in 2024
- Achieved $1.81 million gain from derivative liability changes
- Maintained strong gross margin of 64% in Q1 2025
- Operating cash flow improved to -$873,632 from -$1,079,014
- Successfully reduced advertising expenses by 84% through cost-efficient marketing
- Revenue remains relatively modest at $4.6 million
- Cash balance limited to $196,000 as of June 30
- Still operating at a net loss despite improvements
- Slightly lower sales reported in Q1 2025
Strong Financial Improvement
For the year ended March 31, 2025, JIVA reported revenue of
This performance reflects JIVA's disciplined approach to cost management and operational efficiency. The Company achieved substantial reductions in advertising, consulting, salaries, and general administrative expenses, while strategically reallocating resources toward sustainable growth initiatives.
Highlights of Fiscal 2025
- Expenses streamlined: Advertising and promotion decreased by
84% compared to 2024, with a shift to more cost-efficient marketing channels. Consulting, legal, and salary expenses also declined significantly. - Other income & gains: The Company benefited from a
gain due to a change in fair value of derivative liability and$1,810,999 in other income, offsetting operational costs.$485,705 - Cash flow improvement: Operating cash flow improved to
from$(873,632) in 2024, highlighting better working capital management.$(1,079,014) - Strengthened balance sheet: Financing activities generated
, primarily from loan proceeds, supporting operations and future growth.$333,461
Q1 Highlights:
- Sales were slightly lower but remained consistent overall
- Gross margin:
64% in Q1 2025 vs.64% in Q2 2025 - Operating income:
in 2025 vs. operating loss of$170 k in 2024$278 k - Improvement primarily driven by lower operating expenses, due to reduced headcount and cost-cutting measures
- Cash balance as of June 30:
$196 k
Positioned for Growth in Wellness Technology
JIVA continues to leverage its unique platform that blends e-commerce technology, immersive wellness environments, and digital communities. With reduced losses and stronger cost controls, the Company is well positioned to pursue strategic opportunities across its brands and joint ventures.
"Fiscal 2025 was a pivotal year for Jiva Technologies. We achieved a dramatic improvement in our bottom line while continuing to build out our ecosystem of wellness-focused platforms," said a spokesperson for JIVA. "Our disciplined cost structure and efficient resource allocation reflect our commitment to long-term sustainable growth, and we are excited about the opportunities ahead."
About JIVA Technologies
JIVA Technologies is dedicated to building niche online wellness communities and creating immersive physical environments. With a proven track record in e-commerce marketplaces, bolstered by expert UI/UX design and SEO, JIVA now focuses on joint ventures to support wellness brands in developing their online presence. The company owns and operates Bloombox Club, an online plant delivery marketplace serving
About LIV3
LIV3 is dedicated to improving metabolic health by addressing the detrimental effects of fructose through its flagship product, SugarShield. Originally introduced through , where the product received overwhelmingly positive feedback for its efficacy, SugarShield features Luteolin, a powerful compound that blocks fructokinase. SugarShield has the potential to reduce cravings, boost energy, and support weight management by preventing fructose metabolism. This innovative approach allows individuals to experience the benefits of a sugar-free lifestyle without making drastic dietary changes. Backed by research, LIV3's solution targets the suspected root cause of metabolic dysfunction and offers a natural, effective way to improve overall health and wellness.
About Best Formulations (a Sirio Company)
Best Formulations, a Sirio Company, is a leading
Contact
Lorne Rapkin
Chief Executive Officer
(416) 419-1415
Forward-looking Information
This press release contains "forward-looking information" within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as "may," "will," "expect," "likely", "should," "would," "plan," "anticipate," "intend," "potential," "proposed," "estimate," "believe" or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions "may" or "will" happen, or by discussions of strategy. The forward-looking information contained herein includes, without limitation, statements regarding the availability of Future Farm products, JIVA Â promotional events and the business and strategic plans of the Company.
By its nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct, and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release including, without limitation: receiving sufficient demand for the Offering; the Company's ability to comply with all applicable governmental regulations including all applicable food safety laws and regulations; impacts to the business and operations of the Company due to the COVID-19 epidemic; the conflict in eastern
Additional risk factors can also be found in the Company's continuous disclosure documents, which have been filed on SEDAR and can be accessed at . Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained applicable herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by law.
Logo -
View original content to download multimedia:
SOURCE JIVA Technologies Inc.